Table 2.
Models | Accuracy | Sensitivity | Specificity | PPV | NPV | AUC |
---|---|---|---|---|---|---|
Peritumoral | 0.724 ± 0.113 | 0.786 ± 0.134 | 0.665 ± 0.158 | 0.723 ± 0.150 | 0.740 ± 0.150 | 0.789 ± 0.099 |
Intratumoral | 0.650 ± 0.125 | 0.738 ± 0.158 | 0.558 ± 0.126 | 0.652 ± 0.138 | 0.658 ± 0.194 | 0.733 ± 0.092 |
Original | 0.669 ± 0.097 | 0.664 ± 0.166 | 0.708 ± 0.154 | 0.716 ± 0.166 | 0.656 ± 0.143 | 0.742 ± 0.079 |
Intratumoral + peritumoral | 0.703 ± 0.125 | 0.703 ± 0.125 | 0.703 ± 0.125 | 0.703 ± 0.125 | 0.703 ± 0.125 | 0.803 ± 0.099 |
Clinical | 0.719 ± 0.100 | 0.739 ± 0.128 | 0.696 ± 0.170 | 0.744 ± 0.114 | 0.715 ± 0.136 | 0.794 ± 0.081 |
Ensemble | 0.756 ± 0.070 | 0.786 ± 0.135 | 0.717 ± 0.132 | 0.773 ± 0.091 | 0.763 ± 0.115 | 0.844 ± 0.063 |
The results of tenfold cross-validation are expressed as mean ± standard deviation
PPV positive predictive value, NPV negative predictive value, AUC area under the curve, CI confidence interval